Gracell Biotechnologies Inc. Gains 23.85%

Fri, Sep 30, 2022 at 07:42 PM

Gracell Biotechnologies Inc. (GRCL:NASDAQ) shot up at $3.22, representing a gain of 23.8%. On Fri, Sep 30, 2022, GRCL:NASDAQ hit a New 2-Week High of $3.22. The stock got featured on our News Catalysts scanner on Wed, Sep 14, 2022 at 08:49 AM in the 'BIOTECH' category. From Fri, Sep 16, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days

About Gracell Biotechnologies Inc. (GRCL:NASDAQ)

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of...

Top 10 Gainers:

SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 43.36%
F45 Training Holdings Inc. (FXLV:NYSE), 41.1%
Avenue Therapeutics, Inc. (ATXI:NASDAQ), 39.03%
Alset EHome International Inc. (AEI:NASDAQ), 30.85%
O2Micro International Limited (OIIM:NASDAQ), 30.15%
PolarityTE, Inc. (PTE:NASDAQ), 27.94%
Pulse Biosciences, Inc. (PLSE:NASDAQ), 27.78%
VectivBio Holding AG (VECT:NASDAQ), 26.05%
Vincerx Pharma Inc. (VINC:NASDAQ), 25.45%
Gracell Biotechnologies Inc. (GRCL:NASDAQ), 23.85%